tiprankstipranks
Advertisement
Advertisement

FR:VLA Stock Latest News

Valneva downgraded to Sell from Neutral at Goldman Sachs
The FlyValneva downgraded to Sell from Neutral at Goldman Sachs
15d ago
VALN
Valneva price target lowered to $11 from $13 at Guggenheim
PremiumThe Fly
Valneva price target lowered to $11 from $13 at Guggenheim
21d ago
VALN
PremiumCompany Announcements
Valneva (0OB3) Balances Vaccine Hopes With Heavy Losses
1M ago
Jefferies says Valneva stock weakness presents buying opportunity
PremiumThe Fly
Jefferies says Valneva stock weakness presents buying opportunity
1M ago
VALN
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
PremiumThe Fly
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
1M ago
PFE
VALN
Elaris FlexCo secures exclusive global license from Valneva
PremiumThe FlyElaris FlexCo secures exclusive global license from Valneva
2M ago
VALN
0OB3 Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0OB3 Earnings this Week: How Will it Perform?
2M ago
Valneva withdraws BLA, IND application for Ixchiq in U.S.
Premium
The Fly
Valneva withdraws BLA, IND application for Ixchiq in U.S.
4M ago
VALN
Valneva, Serum Institute of India discontinue chikungunya vaccine pact
PremiumThe Fly
Valneva, Serum Institute of India discontinue chikungunya vaccine pact
4M ago
VALN
Valneva reports ‘positive’ final Phase 2 results for chikungunya vaccine
PremiumThe Fly
Valneva reports ‘positive’ final Phase 2 results for chikungunya vaccine
5M ago
VALN
Valneva’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Valneva’s Earnings Call: Growth Amid Challenges
5M ago
Valneva’s Promising Future: Buy Rating Backed by Strong Prospects for Lyme Disease Vaccine and Robust Financial Health
PremiumRatings
Valneva’s Promising Future: Buy Rating Backed by Strong Prospects for Lyme Disease Vaccine and Robust Financial Health
6M ago
VALN
0OB3 Earnings this Week: How Will it Perform?
PremiumPre-Earnings0OB3 Earnings this Week: How Will it Perform?
6M ago
Valneva price target lowered to $13 from $14 at Guggenheim
Premium
The Fly
Valneva price target lowered to $13 from $14 at Guggenheim
8M ago
VALN
Valneva’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Valneva’s Earnings Call: Growth Amid Challenges
8M ago
Valneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
PremiumRatings
Valneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
8M ago
VALN
Valneva selloff on FDA suspension overdone, says H.C. Wainwright
PremiumThe Fly
Valneva selloff on FDA suspension overdone, says H.C. Wainwright
8M ago
VALN
Valneva price target lowered to $14 from $18 at Jefferies
PremiumThe Fly
Valneva price target lowered to $14 from $18 at Jefferies
8M ago
VALN
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
PremiumThe Fly
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
8M ago
VALN
Valneva SE (ADR) trading halted, news pending
PremiumThe FlyValneva SE (ADR) trading halted, news pending
9M ago
VALN
Valneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
Premium
Ratings
Valneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
9M ago
VALN
Valneva assumed with a Buy at H.C. Wainwright
Premium
The Fly
Valneva assumed with a Buy at H.C. Wainwright
9M ago
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >